← back to search

Holger Stark

Goethe University Frankfurt · DE
Area of research
Molecular Biology · Immunology
Research interest
Research interests include Mast cells and histamine, Receptor Mechanisms and Signaling, Chemical Synthesis and Analysis, and Olfactory and Sensory Function Studies.
h-index
58
citations
13,372
works
526
NIH funding
primary concept
email

Recent publications

Progress on the development of Class A GPCR‐biased ligands
British Journal of Pharmacology 2024cited by 17position: middledoi
The stimulation of <scp>TH2</scp> cells results in increased <scp>IL</scp>‐5 and <scp>IL</scp>‐13 production via the <scp>H<sub>4</sub></scp> receptor
Allergy 2024cited by 12position: middledoi
Dual Piperidine-Based Histamine H<sub>3</sub> and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain
Journal of Medicinal Chemistry 2023cited by 18position: middledoi
Data from Phosphatidylserine Synthase PTDSS1 Shapes the Tumor Lipidome to Maintain Tumor-Promoting Inflammation
2023cited by 0position: middledoi
Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic Models
Neurology Neuroimmunology & Neuroinflammation 2022cited by 37position: middledoi
Histamine Activates Human Eosinophils via H2R and H4R Predominantly in Atopic Dermatitis Patients
International Journal of Molecular Sciences 2022cited by 35position: middledoi
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H<sub>3</sub> and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties
ACS Chemical Neuroscience 2021cited by 42position: middledoi
Structural modifications in the distal, regulatory region of histamine H3 receptor antagonists leading to the identification of a potent anti-obesity agent
European Journal of Medicinal Chemistry 2020cited by 17position: middledoi
Alkyl derivatives of 1,3,5-triazine as histamine H4 receptor ligands
Bioorganic & Medicinal Chemistry 2019cited by 13position: middledoi
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Journal of Medicinal Chemistry 2018cited by 473position: middledoi
Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies
Nature Communications 2018cited by 158position: middledoi
Multitarget‐Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H<sub>3</sub>R Antagonism for Neurodegenerative Diseases
Angewandte Chemie International Edition 2017cited by 101position: lastdoi
An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C Isoforms
ACS Chemical Biology 2017cited by 23position: middledoi
Human basophil chemotaxis and activation are regulated via the histamine H4 receptor
Allergy 2016cited by 40position: middledoi
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
Pharmacological Reviews 2015cited by 556position: middledoi
Studies on molecular properties prediction and histamine H3 receptor affinities of novel ligands with uracil-based motifs
European Journal of Medicinal Chemistry 2014cited by 12position: lastdoi
Luciferase Reporter Gene Assay on Human, Murine and Rat Histamine H4 Receptor Orthologs: Correlations and Discrepancies between Distal and Proximal Readouts
PLoS ONE 2013cited by 24position: middledoi
Chapter 3 Histamine Metabolism
2013cited by 1position: firstdoi
Chapter 2 Histamine H<sub>4</sub> Receptor Ligands
2013cited by 0position: firstdoi
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
PLoS Computational Biology 2012cited by 264position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 6 papers (2013–2023) · 5 papers (2013–2023)Armin Buschauer · University of Regensburg4 papers (2013–2019)Ralf Gutzmer · University of Duisburg-Essen4 papers (2015–2024)Ewgenij Proschak · Goethe University Frankfurt3 papers (2012–2018) · 3 papers (2019–2021) · 3 papers (2020–2023) · 3 papers (2020–2023)Susanne Mommert · Medizinische Hochschule Hannover3 papers (2016–2024) · 3 papers (2020–2023)Steffen Pockes · University of Regensburg3 papers (2020–2023)S. Dove · University of Regensburg2 papers (2013–2013)Enrique J. Cobos · Universidad de Granada2 papers (2021–2023)Denise Mönnich · University of Regensburg2 papers (2020–2021)Dalibor Odadzic · Frankfurt Cancer Institute2 papers (2014–2017)Thomas Werfel · Vanderbilt University2 papers (2022–2024)Maria Dichiara · Northeastern University2 papers (2021–2023) · 2 papers (2021–2023)Katrin Schaper‐Gerhardt · Medizinische Hochschule Hannover2 papers (2022–2024) · 2 papers (2019–2023)